Thomas Relander
-
- Lymphoma Diagnosis and Treatment 40
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research 8
- Oncology top 5%
- Viral-associated cancers and disorders 11
- CAR-T cell therapy research 9
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 15
- Virus-based gene therapy research 7
- Immunology top 5%
- T-cell and Retrovirus Studies 13
-
- CNS Lymphoma Diagnosis and Treatment 10
In The Last Decade
Thomas Relander
57 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 70
- Pathology and Forensic Medicine 1.1k
- Dermatology 327
- Oncology 754
- Genetics 281
- Immunology 549
Countries citing papers authored by Thomas Relander
This map shows the geographic impact of Thomas Relander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Relander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Relander more than expected).
Fields of papers citing papers by Thomas Relander
This network shows the impact of papers produced by Thomas Relander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Relander. The network helps show where Thomas Relander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Relander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2017 | 16 | |
| 3 | 2016 | 17 | |
| 4 | 2014 | 22 | |
| 5 | 2014 | 1 | |
| 6 | 2012 | 386 | |
| 7 | Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01) | 2012 | 1 |
| 8 | 2011 | 18 | |
| 9 | 2010 | 57 | |
| 10 | Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral t-cell lymphomas (PTCLS) - overall and subtype-specific results of a phase II study from the nordic lymphoma group | 2009 | 20 |
| 11 | 2009 | 48 | |
| 12 | 2008 | 37 | |
| 13 | 2006 | 22 | |
| 14 | 2005 | 5 | |
| 15 | 2004 | 33 | |
| 16 | 2002 | 11 | |
| 17 | 2002 | 9 | |
| 18 | 2001 | 20 | |
| 19 | 2000 | 80 | |
| 20 | 2000 | 4 |
About Thomas Relander
Thomas Relander is a scholar working on Pathology and Forensic Medicine, Genetics, Dermatology, Oncology and Immunology, having authored 58 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (15 papers), T-cell and Retrovirus Studies (13 papers), Viral-associated cancers and disorders (11 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (9 papers), Cutaneous lymphoproliferative disorders research (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Dermatology (327 citations), Oncology (754 citations), Genetics (281 citations) and Immunology (549 citations). Thomas Relander has collaborated with scholars based in Sweden, Denmark and Finland. Frequent co-authors include Mats Jerkeman, Fredrik Ellin, Hans Hagberg, Francesco d’Amore, Martin Erlanson, Joseph M. Connors, Randy D. Gascoyne, Jan Delabie, Outi Kuittinen and Martine Vornanen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Molecular Therapy, The Journal of Gene Medicine and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.